Cargando…

Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) are chronic conditions that primarily affect the gastrointestinal tract, with a complex pathogenesis; they are characterized by a significant heterogeneity of clinical presentations and of inflammatory pathways that sustain intestinal damage. After the introduction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Privitera, Giuseppe, Pugliese, Daniela, Rapaccini, Gian Ludovico, Gasbarrini, Antonio, Armuzzi, Alessandro, Guidi, Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922976/ https://www.ncbi.nlm.nih.gov/pubmed/33669579 http://dx.doi.org/10.3390/jcm10040853

Ejemplares similares

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy
por: Pietropaolo, Giuseppe, et al.
Publicado: (2020)

Update on the management of inflammatory bowel disease: specific role of adalimumab
por: Guidi, Luisa, et al.
Publicado: (2011)

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis
por: Alivernini, Stefano, et al.
Publicado: (2018)

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
por: Scaldaferri, Franco, et al.
Publicado: (2020)

Transition of inflammatory bowel disease patients from pediatric to adult care: an observational study on a joint-visits approach
por: Corsello, Antonio, et al.
Publicado: (2021)

The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”
por: Pugliese, Daniela, et al.
Publicado: (2020)

Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2018)

Frontiers in Drug Research and Development for Inflammatory Bowel Disease
por: Currò, Diego, et al.
Publicado: (2017)

Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab
por: Pugliese, Daniela, et al.
Publicado: (2022)

Diet and Nutrients in Gastrointestinal Chronic Diseases
por: Corsello, Antonio, et al.
Publicado: (2020)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Venous Thromboembolism in Patients with Inflammatory Bowel Disease: The Role of Pharmacological Therapy and Surgery
por: Papa, Alfredo, et al.
Publicado: (2020)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine
por: Felice, Carla, et al.
Publicado: (2019)

Comparative Effectiveness Research: A Roadmap to Sail the Seas of IBD Therapies
por: Pugliese, Daniela, et al.
Publicado: (2022)

FOXP3(+) T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFα Agents
por: Guidi, Luisa, et al.
Publicado: (2013)

Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
por: Pugliese, Daniela, et al.
Publicado: (2016)

Technological advances in inflammatory bowel disease endoscopy and histology
por: Alfarone, Ludovico, et al.
Publicado: (2022)

Novel Topics in Inflammatory Bowel Disease
por: Sakuraba, Atsushi, et al.
Publicado: (2016)

Nurses are Critical in Aiding Patients Transitioning to Biosimilars in Inflammatory Bowel Disease: Education and Communication Strategies
por: Armuzzi, Alessandro, et al.
Publicado: (2019)

Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine
por: Dal Buono, Arianna, et al.
Publicado: (2022)

A rare case of epiploic appendagitis in a patient affected by ulcerative colitis on vedolizumab therapy
por: Pugliese, Daniela, et al.
Publicado: (2022)

Artificial intelligence and inflammatory bowel disease: Where are we going?
por: Da Rio, Leonardo, et al.
Publicado: (2023)

Predicting Treatment Response in Inflammatory Bowel Diseases: Cross-Sectional Imaging Markers
por: Mignini, Irene, et al.
Publicado: (2023)

Hyperbaric oxygen therapy: More hope than hype for future treatment of perianal fistulizing Crohn's disease?
por: Armuzzi, Alessandro, et al.
Publicado: (2022)

Incident Colorectal Cancer in Inflammatory Bowel Disease
por: Neri, Benedetto, et al.
Publicado: (2022)

Mucosal healing in ulcerative colitis: surveillance or colectomy?
por: Andrisani, Gianluca, et al.
Publicado: (2013)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
por: Felice, Carla, et al.
Publicado: (2023)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Biological markers of disease activity in inflammatory bowel diseases
por: Szymanska, Edyta, et al.
Publicado: (2023)

Population-based cohort study on comparative effectiveness and safety of biologics in inflammatory bowel disease
por: Di Domenicantonio, Riccardo, et al.
Publicado: (2018)

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study
por: Pugliese, Daniela, et al.
Publicado: (2018)

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study
por: Pugliese, Daniela, et al.
Publicado: (2022)

Abdominal angina due to recurrence of cancer of the papilla of Vater: a case report
por: Biolato, Marco, et al.
Publicado: (2009)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano
por: Bartocci, Bianca, et al.
Publicado: (2023)

Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections
por: Cavalli, Carolina Aliai Micol, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1vu1t14n3goi71r37cv5q3irfl